GGenetics Read More Opus Genetics Inherited Retinal Disease Programs FeaturedAugust 27, 2025 RESEARCH TRIANGLE PARK, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq:IRD), a clinical-stage biopharmaceutical company…
GGenetics Read More Opus Genetics and the Global RDH12 Alliance Partner toJuly 23, 2025 Collaboration aims to accelerate development of OPGx-RDH12, a gene therapy for RDH12-associated Leber congenital amaurosis (RDH12-LCA) RESEARCH TRIANGLE…